BioCentury
ARTICLE | Distillery Therapeutics

Cancer

April 4, 2017 10:08 PM UTC

Patient sample, cell culture and mouse studies suggest inhibiting ALKBH5 could help treat glioblastoma multiforme (GBM). In patients, high tumor levels of ALKBH5 correlated with poor survival. In thre...